Tech Company Financing Transactions

Kira Pharmaceuticals Funding Round

RA Capital, Vivo Capital and A Plus Finance invested in a $53.5 million Series B funding round for Kira Pharmaceuticals. The round was recorded on 1/8/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Cambridge, MA 02114
USA

Phone

Undisclosed

Website

www.kirapharma.com

Email Address

[email protected]

Overview

Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Frederick Beddingfield

        

Chief Medical Officer

Richard Lee

        

Co-Founder

Gonghua Pan

        

VP - Bus. Development

Kathy He

        

VP - Bus. Development

Dana Zhang

        

VP - R & D

Wenru Song

        

Browse more venture capital transactions:

Prev: 1/8/2021: Scorpion Therapeutics venture capital transaction
Next: 1/8/2021: Ablacon venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary